Cargando…

Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada

BACKGROUND: Individuals with Fetal Alcohol Spectrum Disorder (FASD) constitute a special population that may be at particularly high risk for substance use. The purpose of the current study was to estimate the utilization of specialized addiction treatment services (SATS) and the associated cost, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Popova, Svetlana, Lange, Shannon, Burd, Larry, Urbanoski, Karen, Rehm, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691637/
https://www.ncbi.nlm.nih.gov/pubmed/23758674
http://dx.doi.org/10.1186/1471-2458-13-570
_version_ 1782274502723371008
author Popova, Svetlana
Lange, Shannon
Burd, Larry
Urbanoski, Karen
Rehm, Jürgen
author_facet Popova, Svetlana
Lange, Shannon
Burd, Larry
Urbanoski, Karen
Rehm, Jürgen
author_sort Popova, Svetlana
collection PubMed
description BACKGROUND: Individuals with Fetal Alcohol Spectrum Disorder (FASD) constitute a special population that may be at particularly high risk for substance use. The purpose of the current study was to estimate the utilization of specialized addiction treatment services (SATS) and the associated cost, as a part of the total cost of health care associated with FASD in Canada. METHODS: The current study was a modeling study. Data on SATS by lifetime mental disorder status were obtained from the Drug and Alcohol Treatment Information System (DATIS) in Ontario, Canada for 2010/11. The number of clients with FASD who received SATS in Ontario in 2010/11 was estimated, assuming that approximately 37% (confidence interval: 21.6%-54.5%) of individuals with FASD abuse or are addicted to alcohol and/or drugs and that their utilization rate of SATS is the same as those for people with a lifetime mental disorder. The data from DATIS was then extrapolated to the total Canadian population. RESULTS: The cost of SATS for clients with FASD in Canada in 2010/11 ranged from $1.65 million Canadian dollars (CND) to $3.59 million CND, based on 5,526 outpatient visits and 9,529 resident days. When the sensitivity analysis was performed the cost of SATS ranged from $979 thousand CND to $5.34 million CND. CONCLUSIONS: Special attention must be paid to at-risk groups of individuals such as those with FASD, in order to reduce the likelihood of the development of co-morbid substance abuse problems, and thus, reducing the overall burden on Canadian society.
format Online
Article
Text
id pubmed-3691637
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36916372013-06-26 Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada Popova, Svetlana Lange, Shannon Burd, Larry Urbanoski, Karen Rehm, Jürgen BMC Public Health Research Article BACKGROUND: Individuals with Fetal Alcohol Spectrum Disorder (FASD) constitute a special population that may be at particularly high risk for substance use. The purpose of the current study was to estimate the utilization of specialized addiction treatment services (SATS) and the associated cost, as a part of the total cost of health care associated with FASD in Canada. METHODS: The current study was a modeling study. Data on SATS by lifetime mental disorder status were obtained from the Drug and Alcohol Treatment Information System (DATIS) in Ontario, Canada for 2010/11. The number of clients with FASD who received SATS in Ontario in 2010/11 was estimated, assuming that approximately 37% (confidence interval: 21.6%-54.5%) of individuals with FASD abuse or are addicted to alcohol and/or drugs and that their utilization rate of SATS is the same as those for people with a lifetime mental disorder. The data from DATIS was then extrapolated to the total Canadian population. RESULTS: The cost of SATS for clients with FASD in Canada in 2010/11 ranged from $1.65 million Canadian dollars (CND) to $3.59 million CND, based on 5,526 outpatient visits and 9,529 resident days. When the sensitivity analysis was performed the cost of SATS ranged from $979 thousand CND to $5.34 million CND. CONCLUSIONS: Special attention must be paid to at-risk groups of individuals such as those with FASD, in order to reduce the likelihood of the development of co-morbid substance abuse problems, and thus, reducing the overall burden on Canadian society. BioMed Central 2013-06-11 /pmc/articles/PMC3691637/ /pubmed/23758674 http://dx.doi.org/10.1186/1471-2458-13-570 Text en Copyright © 2013 Popova et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Popova, Svetlana
Lange, Shannon
Burd, Larry
Urbanoski, Karen
Rehm, Jürgen
Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada
title Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada
title_full Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada
title_fullStr Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada
title_full_unstemmed Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada
title_short Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada
title_sort cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in canada
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691637/
https://www.ncbi.nlm.nih.gov/pubmed/23758674
http://dx.doi.org/10.1186/1471-2458-13-570
work_keys_str_mv AT popovasvetlana costofspecializedaddictiontreatmentofclientswithfetalalcoholspectrumdisorderincanada
AT langeshannon costofspecializedaddictiontreatmentofclientswithfetalalcoholspectrumdisorderincanada
AT burdlarry costofspecializedaddictiontreatmentofclientswithfetalalcoholspectrumdisorderincanada
AT urbanoskikaren costofspecializedaddictiontreatmentofclientswithfetalalcoholspectrumdisorderincanada
AT rehmjurgen costofspecializedaddictiontreatmentofclientswithfetalalcoholspectrumdisorderincanada